Xinmin Yu

Xinmin Yu

UNVERIFIED PROFILE

Are you Xinmin Yu?   Register this Author

Register author
Xinmin Yu

Xinmin Yu

Publications by authors named "Xinmin Yu"

Are you Xinmin Yu?   Register this Author

42Publications

733Reads

19Profile Views

Apatinib for chemotherapy-refractory extensive-stage SCLC: a retrospective study.

Cancer Chemother Pharmacol 2019 Jun 1;83(6):1083-1090. Epub 2019 Apr 1.

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-019-03823-4DOI Listing
June 2019

Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.

Lung Cancer 2019 05 20;131:62-68. Epub 2019 Mar 20.

Department of Medical Oncology, Zhejiang Cancer Hospital, China; Zhejiang Key Laboratory of Diagnosis and Treatment Technology of Thoracic Oncology, China. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002193037
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2019.03.018DOI Listing
May 2019

Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas.

Lung Cancer 2018 10 29;124:110-116. Epub 2018 Jul 29.

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China; Zhejiang Key Laboratory of Diagnosis and Treatment Technology of Thoracic Oncology, Hangzhou, Zhejiang, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.07.039DOI Listing
October 2018

Clinicopathologic characteristics and survival outcome in patients with advanced lung adenocarcinoma and mutation.

J Cancer 2018 30;9(16):2930-2937. Epub 2018 Jul 30.

Department of Medical Oncology, Zhejiang Cancer Hospital.

View Article

Download full-text PDF

Source
http://www.jcancer.org/v09p2930.htm
Publisher Site
http://dx.doi.org/10.7150/jca.24425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096359PMC
July 2018

A real-world study of treatment patterns and survival outcome in advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer.

Oncol Lett 2018 Jun 5;15(6):8703-8710. Epub 2018 Apr 5.

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2018.8444DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958653PMC
June 2018

Clinicopathological characteristics and survival of ALK, ROS1 and RET rearrangements in non-adenocarcinoma non-small cell lung cancer patients.

Cancer Biol Ther 2017 Nov 16;18(11):883-887. Epub 2016 Sep 16.

a Department of Medical Oncology , Zhejiang Cancer Hospital , Hangzhou , China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15384047.2016.1235660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710698PMC
November 2017

Molecular Profiling and Survival of Completely Resected Primary Pulmonary Neuroendocrine Carcinoma.

Clin Lung Cancer 2017 05 2;18(3):e197-e201. Epub 2016 Dec 2.

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China; Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Hangzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.11.014DOI Listing
May 2017

Salvage treatment with apatinib for advanced non-small-cell lung cancer.

Onco Targets Ther 2017 23;10:1821-1825. Epub 2017 Mar 23.

Department of Chemotherapy, Zhejiang Cancer Hospital; Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang province, Hangzhou, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S113435DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370069PMC
March 2017

Clinicopathologic characteristics, genetic variability and therapeutic options of RET rearrangements patients in lung adenocarcinoma.

Lung Cancer 2016 11 9;101:16-21. Epub 2016 Sep 9.

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China; Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang Province, Hangzhou 310022, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.09.002DOI Listing
November 2016

HER2 mutations in Chinese patients with non-small cell lung cancer.

Oncotarget 2016 Nov;7(47):78152-78158

Department of Medical Oncology , Zhejiang Cancer Hospital, Hangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.11313DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363651PMC
November 2016

Mutation and prognostic analyses of PIK3CA in patients with completely resected lung adenocarcinoma.

Cancer Med 2016 10 23;5(10):2694-2700. Epub 2016 Aug 23.

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, 310022, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.852DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083721PMC
October 2016

Rare frequency of gene variation and survival analysis in thymic epithelial tumors.

Onco Targets Ther 2016 14;9:6337-6342. Epub 2016 Oct 14.

Department of Medical Oncology, Zhejiang Cancer Hospital; Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang Province, Hangzhou, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S108749DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5072509PMC
October 2016

Altered expression of programmed death-ligand 1 after neo-adjuvant chemotherapy in patients with lung squamous cell carcinoma.

Lung Cancer 2016 09 15;99:166-71. Epub 2016 Jul 15.

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China; Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang province, Hangzhou 310022, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.07.013DOI Listing
September 2016

Comparison of the 7(th) and proposed 8(th) editions of the AJCC/UICC TNM staging system for non-small cell lung cancer undergoing radical surgery.

Sci Rep 2016 09 19;6:33587. Epub 2016 Sep 19.

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep33587DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027530PMC
September 2016

Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer.

Sci Rep 2016 08 16;6:31636. Epub 2016 Aug 16.

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep31636DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985828PMC
August 2016

Programmed death-ligand 1 expression associated with molecular characteristics in surgically resected lung adenocarcinoma.

J Transl Med 2016 06 24;14(1):188. Epub 2016 Jun 24.

Department of Medical Oncology, Zhejiang Cancer Hospital, 38 Guangji Road, Hangzhou, 310022, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-016-0943-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919857PMC
June 2016

Chemotherapy and prognosis in advanced thymic carcinoma patients.

Clinics (Sao Paulo) 2015 Dec;70(12):775-80

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6061/clinics/2015(12)03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676312PMC
December 2015

[Efficacy of crizotinib for 28 cases of advanced ALK-positive non-small cell lung cancer].

Zhonghua Zhong Liu Za Zhi 2015 Oct;37(10):784-7

Department of Thoracic Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China; Email:

View Article

Download full-text PDF

Source
October 2015

Prognostic value of programed death ligand 1 in patients with solid tumors: A meta-analysis.

J Cancer Res Ther 2015 Aug;11 Suppl 1:C38-43

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0973-1482.163837DOI Listing
August 2015

Nanoscale zero-valent iron/AC as heterogeneous Fenton catalysts in three-dimensional electrode system.

Environ Sci Pollut Res Int 2014 28;21(14):8398-405. Epub 2014 Mar 28.

Key Laboratory of Pollution Process and Environmental Criteria, Ministry of Education, Tianjin, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11356-014-2791-1DOI Listing
May 2015

Recent updates on electrochemical degradation of bio-refractory organic pollutants using BDD anode: a mini review.

Environ Sci Pollut Res Int 2014 29;21(14):8417-31. Epub 2014 Apr 29.

Key Laboratory of Pollution Process and Environmental Criteria, Ministry of Education, College of Environmental Science and Engineering, Nankai University, Tianjin, 300071, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11356-014-2820-0DOI Listing
May 2015

Treatment and prognosis of Masaoka stage 3 thymic carcinoma: a retrospective study of 32 cases.

Onco Targets Ther 2015 6;8:699-702. Epub 2015 Apr 6.

Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Hangzhou, People's Republic of China ; Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S78791DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396510PMC
April 2015

Heterogeneous electro-Fenton using modified iron-carbon as catalyst for 2,4-dichlorophenol degradation: influence factors, mechanism and degradation pathway.

Water Res 2015 Mar 20;70:414-24. Epub 2014 Dec 20.

Key Laboratory of Pollution Process and Environmental Criteria, Ministry of Education, College of Environmental Science and Engineering, Nankai University, Tianjin 300071, China; Tianjin Key Laboratory of Urban Ecology Environmental Remediation and Pollution Control, College of Environmental Science and Engineering, Nankai University, Tianjin 300071, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.watres.2014.12.022DOI Listing
March 2015

Efficacy and safety of icotinib in Chinese patients with advanced non-small cell lung cancer after failure of chemotherapy.

Chin Med J (Engl) 2014 ;127(2):266-71

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China; Key Laboratory of Diagnosis and Technology on Thoracic Oncology, Hangzhou, Zhejiang 310022, China. Email:

View Article

Download full-text PDF

Source
January 2015

Meta-analysis to assess the efficacy and toxicity of docetaxel-based doublet compared with docetaxel alone for patients with advanced NSCLC who failed first-line treatment.

Clin Ther 2014 Dec 23;36(12):1980-1990. Epub 2014 Sep 23.

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2014.08.015DOI Listing
December 2014

Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: a systematic review with meta-analysis.

J Cancer Res Ther 2014 Nov;10 Suppl:C160-6

Department of Medical Oncology, Zhejiang Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology (Lung and Esophagus), Zhejiang Cancer Hospital, Hangzhou 310022, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0973-1482.145854DOI Listing
November 2014

Chemoradiotherapy is superior to radiotherapy alone after surgery in advanced squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.

Int J Clin Exp Med 2014 15;7(9):2478-87. Epub 2014 Sep 15.

Department of Head and Neck Surgery, Zhejiang Cancer Hospital Hangzhou 310022, China.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211750PMC
October 2014

Renal metastasis after esophagectomy of esophageal squamous cell carcinoma: a case report and literature review.

World J Surg Oncol 2014 May 26;12:165. Epub 2014 May 26.

Department of Chemotherapy, Zhejiang Cancer Hospital, 38 Guangji Road, 310022 Hangzhou, P,R, of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1477-7819-12-165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037410PMC
May 2014

Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.

World J Surg Oncol 2014 May 19;12:148. Epub 2014 May 19.

Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, 38 Guangji road, Zhejiang province, Hangzhou 310022, People's Republic of China.

View Article

Download full-text PDF

Source
http://wjso.biomedcentral.com/articles/10.1186/1477-7819-12-
Publisher Site
http://dx.doi.org/10.1186/1477-7819-12-148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067105PMC
May 2014

Docetaxel-based chemotherapy as second-line regimen for advanced thymic carcinoma.

Thorac Cancer 2014 03 3;5(2):169-73. Epub 2014 Mar 3.

Department of Chemotherapy, Zhejiang Cancer Hospital Hangzhou, China; Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology Hangzhou, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1759-7714.12064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704314PMC
March 2014

Re-administration after the failure of gefitinib or erlotinib in patients with advanced non-small cell lung cancer.

J Thorac Dis 2013 Aug;5(4):400-5

Department of Chemotherapy, Zhejiang Cancer Hospital, Hangzhou 310022, China; ; Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Hangzhou 310022, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2072-1439.2013.07.28DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755689PMC
August 2013

Analysis of new N-category on prognosis of oesophageal cancer with positive lymph nodes in a Chinese population.

Radiol Oncol 2013 Mar 1;47(1):63-70. Epub 2013 Feb 1.

Department of Radiation Oncology; Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2478/v10019-012-0039-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573836PMC
March 2013

Neoadjuvant versus adjuvant treatment: which one is better for resectable esophageal squamous cell carcinoma?

World J Surg Oncol 2012 Aug 25;10:173. Epub 2012 Aug 25.

Department of Thoracic Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, People's Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1477-7819-10-173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495900PMC
August 2012

Treatment of brain metastasis from non-small cell lung cancer with whole brain radiotherapy and Gefitinib in a Chinese population.

Lung Cancer 2009 Aug 16;65(2):198-203. Epub 2008 Dec 16.

Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, PR China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2008.10.028DOI Listing
August 2009

Induction of p21 by p65 in p53 null cells treated with Doxorubicin.

Biochim Biophys Acta 2008 May 26;1783(5):935-40. Epub 2008 Jan 26.

Zhejiang Tumor Hospital, Banshanqiao,Hangzhou, Zhejiang Province, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbamcr.2008.01.008DOI Listing
May 2008